Patrick Phillips

10.8k total citations · 2 hit papers
120 papers, 3.4k citations indexed

About

Patrick Phillips is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Patrick Phillips has authored 120 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Infectious Diseases, 47 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Patrick Phillips's work include Tuberculosis Research and Epidemiology (70 papers), Mycobacterium research and diagnosis (26 papers) and Diagnosis and treatment of tuberculosis (18 papers). Patrick Phillips is often cited by papers focused on Tuberculosis Research and Epidemiology (70 papers), Mycobacterium research and diagnosis (26 papers) and Diagnosis and treatment of tuberculosis (18 papers). Patrick Phillips collaborates with scholars based in United Kingdom, United States and South Africa. Patrick Phillips's co-authors include Andrew Nunn, Stephen H. Gillespie, Timothy D. McHugh, Edward A. Gardner, Sarah Meredith, Angela M. Crook, Carl M. Mendel, Katherine Fielding, Stephen R. Murray and Michael Höelscher and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Medicine.

In The Last Decade

Patrick Phillips

110 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

2014 401 citations Stephen H. Gillespie, Timothy D. McHugh et al. profile →
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

2019 222 citations Andrew Nunn, Patrick Phillips et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Phillips United Kingdom	33	2.2k	1.6k	802	359	255	120	3.4k
Kasia Stepniewska United Kingdom	49	1.4k 0.6×	1.3k 0.8×	670 0.8×	926 2.6×	141 0.6×	126	8.3k
Rodney Dawson South Africa	38	3.3k 1.5×	2.5k 1.6×	1.1k 1.4×	808 2.3×	410 1.6×	82	4.4k
Angela M. Crook United Kingdom	24	1.6k 0.7×	1.1k 0.7×	713 0.9×	302 0.8×	125 0.5×	52	2.6k
Payam Nahid United States	32	3.3k 1.5×	2.5k 1.6×	1.2k 1.5×	964 2.7×	176 0.7×	102	4.6k
Geraint Davies United Kingdom	31	2.1k 0.9×	1.5k 0.9×	559 0.7×	423 1.2×	352 1.4×	136	3.0k
Roxana Rustomjee South Africa	22	3.2k 1.4×	2.5k 1.6×	1.3k 1.7×	594 1.7×	221 0.9×	44	4.0k
Kogieleum Naidoo South Africa	31	3.2k 1.4×	2.2k 1.4×	1.0k 1.3×	366 1.0×	90 0.4×	175	4.1k
Michael Barry Ireland	37	1.8k 0.8×	848 0.5×	340 0.4×	415 1.2×	164 0.6×	219	5.6k
Alexandra Calmy Switzerland	53	6.5k 2.9×	3.2k 2.0×	588 0.7×	436 1.2×	94 0.4×	305	10.1k
Junfeng Sun United States	36	547 0.2×	1.2k 0.8×	670 0.8×	1.0k 2.9×	198 0.8×	159	4.6k

Countries citing papers authored by Patrick Phillips

Since Specialization

Citations

This map shows the geographic impact of Patrick Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Phillips more than expected).

Fields of papers citing papers by Patrick Phillips

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Phillips. The network helps show where Patrick Phillips may publish in the future.

Co-authorship network of co-authors of Patrick Phillips

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Phillips. A scholar is included among the top collaborators of Patrick Phillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Phillips. Patrick Phillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Phillips, Patrick, Charles A. Peloquin, Andreas H. Diacon, et al.. (2025). Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 211(7). 1277–1287. 1 indexed citations

Heinrich, Norbert, Veronique de Jager, Patrick Phillips, et al.. (2025). Population pharmacokinetics and exposure–response relationship of the antituberculosis drug BTZ-043. Journal of Antimicrobial Chemotherapy. 80(5). 1315–1323. 1 indexed citations

Weir, Isabelle R., Suzanne M. Dufault, & Patrick Phillips. (2024). Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial. Trials. 25(1). 180–180. 2 indexed citations

Aschmann, Hélène E., Christopher A. Berger, Noah Kiwanuka, et al.. (2024). Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda. Open Forum Infectious Diseases. 11(11). ofae667–ofae667. 1 indexed citations

Crowder, Rebecca, Alfred Andama, Devasahayam Jesudas Christopher, et al.. (2024). Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein. Clinical Infectious Diseases. 82(2). e239–e247. 1 indexed citations

Mpagama, Stellah, Hadija Semvua, Derek J. Sloan, et al.. (2023). Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania. Pilot and Feasibility Studies. 9(1). 55–55. 2 indexed citations

Phillips, Patrick, Caryn M. Upton, Jakko van Ingen, et al.. (2023). Early bactericidal activity studies for pulmonary tuberculosis: A systematic review of methodological aspects. International Journal of Antimicrobial Agents. 61(5). 106775–106775. 8 indexed citations

Kritski, Afrânio Lineu, Martha Maria Oliveira, Mônica Kramer de Noronha Andrade, et al.. (2022). Clinical Impact of the Line Probe Assay and Xpert® MTB/RIF Assay in the Presumptive Diagnosis of Drug-Resistant Tuberculosis in Brazil: A Pragmatic Clinical Trial. Revista da Sociedade Brasileira de Medicina Tropical. 55. e0191–e0191. 3 indexed citations

Mpolya, Emmanuel, Elingarami Sauli, Bariki Mtafya, et al.. (2021). Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania. Journal of Clinical Microbiology. 59(4). 15 indexed citations

10.

Phillips, Patrick. (2021). Critical Black Futurism: Affecting Affinities within Curriculum Studies. 14(2). 2 indexed citations

11.

Imperial, Marjorie Z., Patrick Phillips, Payam Nahid, & Radojka M. Savić. (2021). Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials. American Journal of Respiratory and Critical Care Medicine. 204(9). 1086–1096. 26 indexed citations

12.

Phillips, Patrick. (2020). A systematic review of estimand and endpoint definitions in recent phase III trials in DS-TB and DR-TB: Preliminary Results. Figshare. 1 indexed citations

13.

Zakeri, Rosita, John M. Morgan, Patrick Phillips, et al.. (2020). Impact of Remote Monitoring on Clinical Outcomes for Patients with Heart Failure and Atrial Fibrillation: Results from the REM-HF Trial. European Journal of Heart Failure. 22(3). 543–553. 22 indexed citations

14.

Alipanah, Narges, Priya B. Shete, Nguyen Viet Nhung, et al.. (2019). Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening. Diagnostics. 9(2). 56–56. 2 indexed citations

15.

Phillips, Patrick, Carole D. Mitnick, James D. Neaton, et al.. (2019). Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape. PLoS Medicine. 16(3). e1002767–e1002767. 15 indexed citations

16.

Morris, Tim P., Christopher I Jarvis, William J Cragg, et al.. (2019). Proposals on Kaplan–Meier plots in medical research and a survey of stakeholder views: KMunicate. BMJ Open. 9(9). e030215–e030215. 24 indexed citations

17.

Stout, Jason E., Nicholas Turner, Robert Belknap, et al.. (2019). Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling. American Journal of Respiratory and Critical Care Medicine. 201(5). 598–605. 2 indexed citations

18.

Rehal, Sunita, Tim P. Morris, Katherine Fielding, James R. Carpenter, & Patrick Phillips. (2016). Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals. BMJ Open. 6(10). e012594–e012594. 101 indexed citations

19.

Boeree, Martin J., Andreas H. Diacon, Rodney Dawson, et al.. (2015). A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 191(9). 1058–1065. 213 indexed citations

20.

Nahid, Payam, Jussi Saukkonen, William R. Mac Kenzie, et al.. (2011). Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap. American Journal of Respiratory and Critical Care Medicine. 184(8). 972–979. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact